电子健康：低发酵性寡糖、双糖、单糖和多元醇饮食与鼠李糖乳杆菌GG治疗肠易激综合征的比较

Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.

作者信息

Pedersen Natalia, Andersen Nynne Nyboe, Végh Zsuzsanna, Jensen Lisbeth, Ankersen Dorit Vedel, Felding Maria, Simonsen Mette Hestetun, Burisch Johan, Munkholm Pia

机构信息

Natalia Pedersen, Johan Burisch, Pia Munkholm, Digestive Disease Centre, Medical Section, Herlev University Hospital, 2730 Copenhagen, Denmark.

出版信息

World J Gastroenterol. 2014 Nov 21;20(43):16215-26. doi: 10.3748/wjg.v20.i43.16215.

DOI:10.3748/wjg.v20.i43.16215

PMID:25473176

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4239510/

Abstract

AIM

To investigate the effects of a low fermentable, oligosaccharides, disaccharides, monosaccharides and polyols diet (LFD) and the probiotic Lactobacillus rhamnosus GG (LGG) in irritable bowel syndrome (IBS).

METHODS

Randomised, unblinded controlled trial on the effect of 6-wk treatment with LFD, LGG or a normal Danish/Western diet (ND) in patients with IBS fulfilling Rome III diagnostic criteria, recruited between November 2009 and April 2013. Patients were required to complete on a weekly basis the IBS severity score system (IBS-SSS) and IBS quality of life (IBS-QOL) questionnaires in a specially developed IBS web self-monitoring application. We investigated whether LFD or LGG could reduce IBS-SSS and improve QOL in IBS patients.

RESULTS

One hundred twenty-three patients (median age 37 years, range: 18-74 years), 90 (73%) females were randomised: 42 to LFD, 41 to LGG and 40 to ND. A significant reduction in mean ± SD of IBS-SSS from baseline to week 6 between LFD vs LGG vs ND was revealed: 133 ± 122 vs 68 ± 107, 133 ± 122 vs 34 ± 95, P < 0.01. Adjusted changes of IBS-SSS for baseline covariates showed statistically significant reduction of IBS-SSS in LFD group compared to ND (IBS-SSS score 75; 95%CI: 24-126, P < 0.01), but not in LGG compared to ND (IBS-SSS score 32; 95%CI: 18-80, P = 0.20). IBS-QOL was not altered significantly in any of the three groups: mean ± SD in LFD 8 ± 18 vs LGG 7 ± 17, LFD 8 ± 18 vs ND 0.1 ± 15, P = 0.13.

CONCLUSION

Both LFD and LGG are efficatious in patients with IBS.

摘要

目的

研究低可发酵寡糖、双糖、单糖和多元醇饮食（LFD）及益生菌鼠李糖乳杆菌GG（LGG）对肠易激综合征（IBS）的影响。

方法

对2009年11月至2013年4月招募的符合罗马III诊断标准的IBS患者进行一项关于LFD、LGG或正常丹麦/西方饮食（ND）6周治疗效果的随机、非盲对照试验。患者需在一个专门开发的IBS网络自我监测应用程序中每周完成肠易激综合征严重程度评分系统（IBS-SSS）和肠易激综合征生活质量（IBS-QOL）问卷。我们研究了LFD或LGG是否能降低IBS患者的IBS-SSS并改善生活质量。

结果

123名患者（中位年龄37岁，范围：18 - 74岁），90名（73%）女性被随机分组：42名接受LFD，41名接受LGG，40名接受ND。结果显示，从基线到第6周，LFD组、LGG组和ND组的IBS-SSS均值±标准差有显著降低：133±122对比68±107，133±122对比34±95，P<0.01。对基线协变量调整后的IBS-SSS变化显示，与ND组相比，LFD组的IBS-SSS有统计学意义的降低（IBS-SSS评分75；95%CI：24 - 126，P<0.01），但LGG组与ND组相比无显著降低（IBS-SSS评分32；95%CI：18 - 80，P = 0.20）。三组中任何一组的IBS-QOL均无显著改变：LFD组均值±标准差为8±18，LGG组为7±17，LFD组8±18对比ND组0.1±15，P = 0.13。

结论

LFD和LGG对IBS患者均有效。

相似文献

Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.电子健康：低发酵性寡糖、双糖、单糖和多元醇饮食与鼠李糖乳杆菌GG治疗肠易激综合征的比较

World J Gastroenterol. 2014 Nov 21;20(43):16215-26. doi: 10.3748/wjg.v20.i43.16215.

Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease.低FODMAP饮食可减轻炎症性肠病患者的肠易激症状。

World J Gastroenterol. 2017 May 14;23(18):3356-3366. doi: 10.3748/wjg.v23.i18.3356.

Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet.采用低发酵性寡糖、双糖、单糖和多元醇饮食治疗的肠易激综合征患者的电子健康监测

World J Gastroenterol. 2014 Jun 7;20(21):6680-4. doi: 10.3748/wjg.v20.i21.6680.

The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome.患有肠易激综合征患者的低可发酵性寡糖、双糖、单糖和多元醇（FODMAP）饮食的长期效果和依从性。

J Hum Nutr Diet. 2020 Apr;33(2):159-169. doi: 10.1111/jhn.12706. Epub 2019 Oct 22.

Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial.低可发酵寡糖、双糖、单糖和多元醇饮食用于腹泻型肠易激综合征患者：一项前瞻性随机试验。

J Gastroenterol Hepatol. 2021 Aug;36(8):2107-2115. doi: 10.1111/jgh.15410. Epub 2021 Feb 4.

A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.低 FODMAP 饮食可减轻肠易激综合征患者的症状，益生菌可恢复双歧杆菌属：一项随机对照试验。

Gastroenterology. 2017 Oct;153(4):936-947. doi: 10.1053/j.gastro.2017.06.010. Epub 2017 Jun 15.

Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.基于网络的低 FODMAP 饮食与益生菌治疗肠易激综合征的长期疗效，包括对微生物组的 shotgun 分析：随机、双交叉临床试验。

J Med Internet Res. 2021 Dec 14;23(12):e30291. doi: 10.2196/30291.

Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.采用低FODMAP饮食治疗的功能性肠症状患者的随访。

World J Gastroenterol. 2016 Apr 21;22(15):4009-19. doi: 10.3748/wjg.v22.i15.4009.

A diet low in fermentable oligo-, di-, monosaccharides and polyols improves abdominal and overall symptoms in persons with all subtypes of irritable bowel syndrome.低发酵寡糖、二糖、单糖和多元醇饮食可改善所有亚型肠易激综合征患者的腹部和整体症状。

Neurogastroenterol Motil. 2024 Aug;36(8):e14845. doi: 10.1111/nmo.14845. Epub 2024 Jun 17.

Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.与标准肠易激综合征（IBS）饮食相比，低可发酵寡糖、双糖、单糖和多元醇（FODMAP）饮食可改善成人肠易激综合征（IBS）的症状：一项临床研究的荟萃分析。

PLoS One. 2017 Aug 14;12(8):e0182942. doi: 10.1371/journal.pone.0182942. eCollection 2017.

引用本文的文献

A 12-Week Strict Low FODMAP Diet Reduces the Severity Levels of Fatigue, Depression, Anxiety, and Inattention in Patients with Irritable Bowel Syndrome.为期12周的严格低FODMAP饮食可降低肠易激综合征患者的疲劳、抑郁、焦虑和注意力不集中的严重程度。

Curr Dev Nutr. 2025 Jun 6;9(7):107483. doi: 10.1016/j.cdnut.2025.107483. eCollection 2025 Jul.

Clinical Evidence on the Health Benefits and Safety of Probiotic Lacticaseibacillus rhamnosus: A Systematic Review.鼠李糖乳杆菌益生菌对健康益处及安全性的临床证据：一项系统综述。

Probiotics Antimicrob Proteins. 2025 Jul 11. doi: 10.1007/s12602-025-10646-8.

The association between fodmaps intake and psychological disorders in a large sample of Iranian adults.大量伊朗成年人中可发酵低聚糖、双糖、单糖和多元醇（FODMAPs）摄入量与心理障碍之间的关联。

Sci Rep. 2025 Jul 8;15(1):24355. doi: 10.1038/s41598-025-08326-2.

Clinical Trial: A Mediterranean Low-FODMAP Diet Alleviates Symptoms of Non-Constipation IBS-Randomized Controlled Study and Volatomics Analysis.临床试验：地中海低发酵性寡糖、双糖、单糖和多元醇饮食缓解非便秘型肠易激综合征症状——随机对照研究及挥发物分析

Nutrients. 2025 Apr 30;17(9):1545. doi: 10.3390/nu17091545.

The effect of low-FODMAP diet on patients with irritable bowel syndrome.低发酵性寡糖、双糖、单糖和多元醇饮食对肠易激综合征患者的影响。

Sci Rep. 2025 May 11;15(1):16382. doi: 10.1038/s41598-025-01163-3.

2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome.《2025年肠易激综合征临床实践指南首尔共识》

J Neurogastroenterol Motil. 2025 Apr 30;31(2):133-169. doi: 10.5056/jnm25007.

Low-FODMAP Diet for Irritable Bowel Syndrome: Insights from Microbiome.用于肠易激综合征的低FODMAP饮食：来自微生物组的见解

Nutrients. 2025 Jan 31;17(3):544. doi: 10.3390/nu17030544.

The Efficacy of the Low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) Diet in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.低可发酵寡糖、双糖、单糖和多元醇（FODMAP）饮食对肠易激综合征的疗效：一项系统评价和荟萃分析。

Cureus. 2025 Jan 7;17(1):e77053. doi: 10.7759/cureus.77053. eCollection 2025 Jan.

Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.益生菌在肠易激综合征管理中的疗效：一项系统评价与荟萃分析。

Cureus. 2024 Dec 18;16(12):e75954. doi: 10.7759/cureus.75954. eCollection 2024 Dec.

Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review.用于治疗肠易激综合征的益生菌和益生元——一篇叙述性综述

J Clin Med. 2024 Oct 23;13(21):6337. doi: 10.3390/jcm13216337.

本文引用的文献

Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome.负性情绪在肠易激综合征病理生理学及临床表现中的作用

World J Gastroenterol. 2014 Jun 28;20(24):7570-86. doi: 10.3748/wjg.v20.i24.7570.

Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.肠易激综合征：发病机制、诊断、治疗及循证医学

World J Gastroenterol. 2014 Jun 14;20(22):6759-73. doi: 10.3748/wjg.v20.i22.6759.

World J Gastroenterol. 2014 Jun 7;20(21):6680-4. doi: 10.3748/wjg.v20.i21.6680.

A cross-sectional study of irritable bowel syndrome in nurses in China: prevalence and associated psychological and lifestyle factors.中国护士肠易激综合征的横断面研究：患病率及相关心理和生活方式因素

J Zhejiang Univ Sci B. 2014 Jun;15(6):590-7. doi: 10.1631/jzus.B1300159.

Predictive factors for the diagnosis of irritable bowel syndrome in a large cohort of 440,822 young adults.440,822名年轻成年人的大型队列中肠易激综合征诊断的预测因素

J Clin Gastroenterol. 2015 Apr;49(4):300-5. doi: 10.1097/MCG.0000000000000114.

Distance management of inflammatory bowel disease: systematic review and meta-analysis.炎症性肠病的远程管理：系统评价与荟萃分析

World J Gastroenterol. 2014 Jan 21;20(3):829-42. doi: 10.3748/wjg.v20.i3.829.

Functional bowel symptoms and diet.功能性肠病症状与饮食

Intern Med J. 2013 Oct;43(10):1067-74. doi: 10.1111/imj.12266.

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.低 FODMAP 饮食可减轻肠易激综合征症状。

Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25.

What role does wheat play in the symptoms of irritable bowel syndrome?小麦在肠易激综合征的症状中起什么作用？

Gastroenterol Hepatol (N Y). 2013 Feb;9(2):85-91.

Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.系统评价：益生菌在临床实践中治疗下消化道症状的应用——循证国际指南。

Aliment Pharmacol Ther. 2013 Oct;38(8):864-86. doi: 10.1111/apt.12460. Epub 2013 Aug 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。